SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001048477-21-000004
Filing Date
2021-02-25
Accepted
2021-02-25 16:09:32
Documents
16
Period of Report
2021-02-25
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20210225.htm   iXBRL 8-K 33317
2 EX-99.1 bmrn-21xfeb25xex991.htm EX-99.1 342666
8 bmrnlogoa011a.jpg GRAPHIC 3615
  Complete submission text file 0001048477-21-000004.txt   554352

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20210225.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20210225_cal.xml EX-101.CAL 803
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20210225_def.xml EX-101.DEF 1767
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20210225_lab.xml EX-101.LAB 24270
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20210225_pre.xml EX-101.PRE 12739
9 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20210225_htm.xml XML 10759
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 21680366
SIC: 2834 Pharmaceutical Preparations